Immunostimulierende Oligonukleotide

European patent · EP2759306 · Deleted

Register entry

Publication number
EP2759306
Application number
EP14161886
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 1, 2009
Published
Jul 30, 2014
Granted
Apr 6, 2016
Deleted
Jul 25, 2023
Reason
Annual fee unpaid
IPC classes
A61K 39/00 (2006.01)
A61K 39/29 (2006.01)
Priority
US 121022 P 09.12.2008
US 181799 P 28.05.2009
Divided from
EP09774978
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 25, 2023

    Deleted, fee unpaid

    Published in Swissreg on 25.07.2023

  2. Apr 6, 2016

    Granted

    Published in Swissreg on 06.04.2016

  3. Apr 6, 2016

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 06.04.2016

Parties

Holder

Coley Pharmaceutical Group, Inc.

235 East 42nd Street, New York, N.Y. 10017-5755, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventor

Davis, Heather Lynn

Ottawa Ontario K2K 3A2, CA

Weeratna, Risini Dhammika

Ottawa Ontario K2K 3A2, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.